Philips To Pay Over $62 Million To Resolve Alleged Foreign Corrupt Practices Violations in China

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

Philips To Pay Over $62 Million To Resolve Alleged Foreign Corrupt Practices Violations in China

Dennis Tosh

May 18, 2023 at 12:04 PM EST

Koninklijke Philips N.V. has agreed to pay the Securities and Exchange Commission (SEC) more than $62 million to resolve allegations that the Netherlands-based device manufacturer violated the Foreign Corrupt Practices Act (FCPA) by providing illicit price discounts and engaging in other illegal activity related to its sales of medical diagnostic equipment in China (In re Koni... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

Philips To Pay Over $62 Million To Resolve Alleged Foreign Corrupt Practices Violations in China

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT